Reevaluating the Need for Routine <scp>IGF</scp> ‐1 Screening in Poorly Controlled Type 2 Diabetes Mellitus
Routine IGF-1 screening in all patients with poorly controlled type 2 DM has limited diagnostic yield. IGF-1 testing should be reserved for patients exhibiting clinical features or phenotypic suspicion of acromegaly.
Authors
- Sema Hepşen (ORCID: https://orcid.org/0000-0002-8375-7409)
- Hayri Bostan (ORCID: https://orcid.org/0000-0002-4957-9856)
- Hakan Düğer (ORCID: https://orcid.org/0000-0001-5478-3192)
- Muhammed Kizilgul
- Bekir Ucan
- Erman Cakal
- Umran Gul
- Munire Topalak Sonmez
Institutions
- University of Minnesota (US)
- Canakkale Onsekiz Mart Universitesi Tip Fakultesi Hastanesi (TR)
- Memorial Ankara Hospital (TR)
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Antalya IVF (TR)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2026-03-01
- DOI
- https://doi.org/10.1002/edm2.70194
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00